Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09BJH
|
|||
| Former ID |
DIB015915
|
|||
| Drug Name |
Retroviral MGMT-transduced hematopoietic cells
|
|||
| Synonyms |
G156A MGMT+; Retroviral MGMT-transduced hematopoietic cells (hematopoiesis protection); Autologous MFG-G156A MGMT-transduced CD34+ therapy; Methyltransferase-transduced autologous cell therapy (hematopoiesis protection), Case Western; Retroviral MGMT-transduced hematopoietic cells (hematopoiesisprotection), Case Western
Click to Show/Hide
|
|||
| Indication | Anemia [ICD-11: 3A00-3A9Z; ICD-9: 280-285] | Phase 1 | [1] | |
| Company |
Case Western Reserve University
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication. Mol Ther. 2004 Feb;9(2):160-72. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.